Elmind Capital, LP — 13F Portfolio

Elmind Capital, LP is an alternative investment manager that files Form 13F with the SEC under CIK #0002052213. As a 13F reporting manager, Elmind’s publicly reportable U.S. equity positions (and certain related instruments) are disclosed quarterly, providing a recurring window into its long, reportable holdings. Elmind Capital is associated with New York, NY in industry references and is generally characterized as a hedge fund-style manager. The Form 13F framework does not disclose the full balance sheet or complete exposure set (e.g., shorts, many derivatives, non-U.S. listings, private investments, or credit instruments held outside reportable 13F categories). Accordingly, the 13F should be treated as a partial but standardized view of positioning rather than a complete representation of the firm’s total portfolio. Within the platform, Elmind’s 13F History can be used to reconstruct the sequence of disclosed holdings, identify recurring themes, and track changes in sizing and concentration across reporting periods.

Elmind Capital is best understood as a fundamentally oriented, opportunistic manager that expresses views through a set of public securities that can include equities and equity-linked positions visible in 13F snapshots. While any definitive statement about mandate constraints must be grounded in primary sources (e.g., offering documents) rather than inference, the allocator-relevant framing from 13F evidence is typically around: (i) thematic positioning, (ii) catalyst awareness, and (iii) willingness to size ideas where conviction is high. From a 13F-only lens, the strategy can be analyzed along three practical dimensions: 1) Portfolio construction and conviction Quarterly disclosures allow an allocator to assess whether the disclosed book tends to be concentrated in a smaller number of higher-conviction positions or diversified across many smaller weights. The most direct diagnostic is Top 10 Holdings Concentration over time. 2) Style and factor expression Holdings can be mapped to common equity factors (value, quality, momentum, size) to determine whether the disclosed sleeve exhibits persistent tilts or rotates with regimes. Even for fundamentally driven managers, these exposures often emerge systematically when the same type of situations are repeatedly targeted. 3) Sector and theme implementation Because opportunistic managers may change exposures as catalysts evolve, sector weights may be less stable than bottom-up position selection. Reviewing Sector Allocation History across filings is often more informative than a single-quarter snapshot. If users choose to run a Portfolio Simulator or Backtesting Service, the appropriate use case is historical replication of the disclosed 13F sleeve—treated as an analytical proxy rather than a claim about the fund’s full realized capital trajectory.

Elmind Capital, LP (CIK #0002052213) is a 13F reporting investment manager whose quarterly filings provide a consistent, auditable record of its reportable long U.S. positions. For allocator diligence, the most reliable public evidence is therefore the time series of disclosed holdings—how concentrated the book is, how themes change, and whether factor exposures are stable or episodic. Key takeaways an allocator can typically validate from 13F-based analysis: - The manager’s conviction profile via position sizing and persistence across quarters. - The degree of thematic rotation using sector and industry mapping. - The downside characteristics of the disclosed long sleeve under stress windows, recognizing limitations. Key uncertainties that cannot be resolved from 13F alone: - Net exposure and hedging (shorts, index overlays, options), which can materially change realized risk. - Non-13F asset classes (credit, private investments) that may be central to the broader mandate. Diagnostic regime question: when equity leadership shifts sharply (e.g., from high-beta cyclicals to defensive quality, or from long-duration growth to value), does Elmind’s disclosed positioning historically adapt quickly, or does it maintain exposure such that the portfolio’s sensitivity becomes a defining driver of outcomes?

Elmind Capital’s primary risks, as seen through 13F disclosures, are typically tied to concentration, catalyst timing, and factor/industry crowding. - Concentration and idiosyncratic drawdowns: If the disclosed portfolio periodically concentrates into a small number of names, outcomes can be dominated by a few security-specific paths. - Regime sensitivity: Opportunistic books can exhibit changing factor exposures (e.g., episodic value or cyclicality) that behave differently across inflation, rate, or growth shocks. - Replication gap: Because 13F filings are delayed and do not show shorts or many derivatives, any holdings-based replication can diverge from the manager’s live net exposure. On-platform, a holdings-based replication can be stress-tested using Max Drawdown Depth to contextualize how the disclosed sleeve may have behaved in historical sell-offs. This is best interpreted as “disclosed-long-sleeve downside,” not a complete fund drawdown estimate.